South Street Advisors LLC Abb Vie Inc. Transaction History

South Street Advisors LLC

$658 Million
Q3 2024

A detailed history of South Street Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, South Street Advisors LLC holds 13,961 shares of ABBV stock, worth $2.45 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

13,961

Previous 13,961 -0.0%

Holding current value

$2.45 Million

Previous $2.39 Million 15.16%

% of portfolio

0.42%

Previous 0.36%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $60,213 - $70,315	-389 Reduced 2.71%	13,961 $2.39 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $142,239 - $162,069	-890 Reduced 5.84%	14,350 $2.61 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $359,102 - $446,879	-2,710 Reduced 15.1%	15,240 $2.05 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $69,252 - $79,427	-516 Reduced 2.79%	17,950 $2.41 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $30,276 - $38,491	-220 Reduced 1.18%	18,466 $2.83 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $52,791 - $65,500	-400 Reduced 2.1%	18,686 $3.03 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $189,721 - $240,052	-1,766 Reduced 8.47%	19,086 $2.58 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $50,079 - $55,791	-476 Reduced 2.23%	20,852 $2.35 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $188,743 - $207,783	-1,845 Reduced 7.96%	21,328 $2.31 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $806,992 - $1.09 Million	-10,026 Reduced 30.2%	23,173 $2.48 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $1.5 Million - $2 Million	20,409 Added 159.57%	33,199 $3.26 Million
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $65,700 - $83,980	-1,000 Reduced 7.25%	12,790 $930,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $10.1 Million - $11.9 Million	-131,474 Reduced 90.51%	13,790 $1.11 Million
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $100,893 - $124,428	-1,296 Reduced 0.88%	145,264 $13.4 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $172,040 - $191,255	-1,935 Reduced 1.3%	146,560 $0
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $238,814 - $282,571	-2,660 Reduced 1.76%	148,495 $13.8 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $448,088 - $600,032	-4,870 Reduced 3.12%	151,155 $0
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $616,172 - $675,684	-6,880 Reduced 4.22%	156,025 $15.1 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $11.4 Million - $14.5 Million	162,905	162,905 $0

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on South Street Advisors LLC with notifications on news.

Account

South Street Advisors LLC Abb Vie Inc. Transaction History